Fragile X targeted pharmacotherapy: lessons learned and future directions.
about
Translation in fragile X: no home runs in the first at-bat.The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Translating genetic and preclinical findings into autism therapies.Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells
P2860
Fragile X targeted pharmacotherapy: lessons learned and future directions.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@ast
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@en
type
label
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@ast
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@en
prefLabel
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@ast
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@en
P2093
P2860
P1476
Fragile X targeted pharmacotherapy: lessons learned and future directions.
@en
P2093
Craig A Erickson
David Hessl
Dejan Budimirovic
Elizabeth Berry-Kravis
Ernest V Pedapati
John A Sweeney
Logan K Wink
Matthew H Davenport
Randi J Hagerman
Tori L Schaefer
P2860
P2888
P356
10.1186/S11689-017-9186-9
P577
2017-06-12T00:00:00Z
P6179
1083941571